Windlas Biotech Limited (WINDLAS)

1,144.25

INR
+54.15(+4.97%)
As of December 6, 2024 10:00:00 AM

Windlas Biotech Limited Share Price Information

24 hour Low and High

Low: 1075
High: 1111

All time High

8230.60

Price Change 1h

+₹51.70 +4.73%

Price Change 1d

+₹51.70 +4.73%

Price Change 1w

+₹119.20 +11.63%

Windlas Biotech Limited Market Information

Exchange

NSE

Market Cap

2123.78 Cr

About Windlas Biotech Limited Share

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1154

CEO

Ms. Komal Gupta

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Windlas Biotech's Stock Reaches All-Time High, Outperforms Sector and Sensex
  • Windlas Biotech - 8 healthcare stocks delivered multibagger returns in FY25. Do you own any?
  • Murae Organisor Ltd leads gainers in 'B' group
  • Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up
  • WINDLAS BIOTECH Share Price Today Down 15%

FAQs

Windlas Biotech Limited (WINDLAS)

1,144.25

INR
+54.15(+4.97%)
As of December 6, 2024 10:00:00 AM

Windlas Biotech Limited Share Price Information

24 hour Low and High

Low: 1075
High: 1111

All time High

8230.60

Price Change 1h

+₹51.70 +4.73%

Price Change 1d

+₹51.70 +4.73%

Price Change 1w

+₹119.20 +11.63%

Windlas Biotech Limited Market Information

Exchange

NSE

Market Cap

2123.78 Cr

About Windlas Biotech Limited Share

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1154

CEO

Ms. Komal Gupta

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Windlas Biotech's Stock Reaches All-Time High, Outperforms Sector and Sensex
  • Windlas Biotech - 8 healthcare stocks delivered multibagger returns in FY25. Do you own any?
  • Murae Organisor Ltd leads gainers in 'B' group
  • Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up
  • WINDLAS BIOTECH Share Price Today Down 15%

FAQs